Purchases and Sales Made in Q2 2023 in Collegium Pharmaceutical, Inc (COLL)
This table provides information about the institutional ownership of Collegium Pharmaceutical, Inc (COLL) during Q2 2023. The information is specifically focused on institutions that hold shares of COLLEGIUM PHARMACEUTICAL, INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-85.2K- 6.3% |
$1.79M - $2.05M
|
1.27M
$41.3M
|
|
|
Aug 14, 2023
Q2 2023
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-85.4K- 14.73% |
$1.8M - $2.05M
|
494K
$16.1M
|
|
|
Aug 10, 2023
Q2 2023
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-87.5K- 82.55% |
$1.84M - $2.1M
|
18.5K
$603K
|
|
|
Jul 25, 2023
Q2 2023
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-106K- 40.83% |
$2.22M - $2.54M
|
153K
$4.99M
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-110K- 58.93% |
$2.31M - $2.64M
|
76.5K
$2.49M
|
|
|
Aug 14, 2023
Q2 2023
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-202K- 15.81% |
$4.26M - $4.85M
|
1.08M
$35.1M
|
|
|
Aug 14, 2023
Q2 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-243K- 41.65% |
$5.13M - $5.84M
|
341K
$11.1M
|
|
|
Jul 13, 2023
Q2 2023
|
Cambridge Investment Research Advisors, Inc.
|
SELL
|
- |
-304K- 96.34% |
$6.4M - $7.29M
|
11.5K
$376K
|